Bausch Health
BHC
#3681
Rank
NZ$4.88 B
Marketcap
$13.27
Share price
-2.75%
Change (1 day)
-15.44%
Change (1 year)
Bausch Health is a Canadian company that researches, develops and produces pharmaceuticals and markets patented drugs, generics and non-prescription drugs in the areas of dermatology and ophthalmology.

EPS for Bausch Health (BHC)

EPS in 2023 (TTM): -$4.29

According to Bausch Health 's latest financial reports the company's current EPS (TTM) is -$4.74. In 2022 the company made an earnings per share (EPS) of -$1.11 an increase over its 2021 EPS that were of -$4.74.

EPS history for Bausch Health from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$4.29287.28%
2022-$1.11-76.64%
2021-$4.7468.45%
2020-$2.81-68.91%
2019-$9.05-57.11%
2018-$21.10-272.22%
2017$12.25-199.29%
2016-$12.34798.7%
2015-$1.37-128.31%
2014$4.85-204.62%
2013-$4.64602.7%
2012-$0.66-171.15%
2011$0.93-143.96%
2010-$2.11-206.57%
2009$1.98-11.2%
2008$2.232.46%
2007$2.18-7.58%
2006$2.35-14.29%
2005$2.7554%
2004$1.78-500%
2003-$0.45-141.67%
2002$1.07-4.76%
2001$1.12-175%
2000-$1.50-268%
1999$0.8914.94%
1998$0.7820.83%
1997$0.6453.83%
1996$0.42

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$1.78-62.37%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.48-89.84%๐Ÿ‡บ๐Ÿ‡ธ USA